Study to assess time taken for recovery from anesthetic drugs when it is either purely intravenous or purely inhalational or both inhalational and intravenous in fibroadenoma surgery

Comparison of Recovery Profile of Sevoflurane and Target Controlled Infusion of Propofol in Fibroadenoma Surgeries - A Randomised Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060833

Enrollment

Registered

2023-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: General Anaesthesia (VIMA): Inhalational induction and maintenance of General Anaesthesia for 1 hour Intervention2: General Anaesthesia (TIVA): Intravenous induction and maintenance of

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients scheduled to undergo elective excision and biopsy of fibroadenoma 2. ASA I and II patients 3. Females aged 18-45 years 4. Patients with BMI less than 24.9 5. Patients assessed to have MPC I & II 5. Anticipated surgery duration of less than 1 hour

Exclusion criteria

Exclusion criteria: 1. Patients refusal 2. Anticipated difficult airway 3. Patients with history of GERD 4. Patients with history of achalasia 5. Patients with history of oropharyngeal abscess or mass

Design outcomes

Primary

Measure	Time frame
To compare the recovery profile of patients between Target Controlled Infusion group, Sevoflurane group and Conventional Anaesthesia group using Clinical Recovery ScoreTimepoint: 1hr, 6hr, 12hr, 24hr	—

Secondary

Measure	Time frame
To monitor duration of hospital stay using PADSS ScoreTimepoint: 24hr	—

Countries

India

Contacts

Public ContactDr K Karthik

SRM Institute of Science and Technology

karthikkrishnamoorthy1981@gmail.com9884360796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026